RAS Blockade at Bedtime Versus on Awakening for Aldosterone Breakthrough
NCT01805362
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
104
Enrollment
OTHER
Sponsor class
Conditions
Chronic Kidney Disease
Interventions
OTHER:
Randomization that determine the time of treatment
Sponsor
Centre Hospitalier Universitaire de Nice